OR WAIT null SECS
February 02, 2012
New educational programs are key to the industry's future and to safe, available drugs.
February 01, 2012
The scandal surrounding Servier's diabetes drug, Mediator, continues to unravel in France and could have implications for the whole pharmaceutical industry as the country scrutinises its regulatory systems.
January 02, 2012
The benefits of harmonization may be on industry's wish list, but buying into change is another story.
Recent legal decisions have further divided generic and brand manufacturer cases.
Technology may expedite operations, but the absence of the human element could cost dearly.
January 01, 2012
The next two years may see a shake up in the world's current top pharmaceutical companies, with Pfizer likely to be the only US firm to remain in the top five by sales.
December 02, 2011
Cleanliness is crucial, even if zapping and trapping is necessary to reduce product contamination.
Political leaders need to consider the impact of the biopharmaceutical industry on the economy.
Employee training-at all levels-is crucial for moving forward with a successful risk- and quality-based manufacturing strategy.
December 01, 2011
Where does the time go? It is very hard for me to believe that I am already writing for the final issue of the year, looking back over 2011 and planning for 2012.